774
Views
4
CrossRef citations to date
0
Altmetric
Poison Centre Research

Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicity

, , &
Pages 515-520 | Received 09 Jul 2020, Accepted 11 Sep 2020, Published online: 06 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomasz Gziut & Simon H. L. Thomas. (2022) International trends in systemic human exposures to 2,4 dinitrophenol reported to poisons centres. Clinical Toxicology 60:5, pages 628-631.
Read now

Articles from other publishers (3)

Ali Abdelati, Michele M. Burns & Michael Chary. (2023) Sublethal toxicities of 2,4-dinitrophenol as inferred from online self-reports. PLOS ONE 18:9, pages e0290630.
Crossref
Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi & Fabrizio Schifano. (2023) Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals 16:7, pages 994.
Crossref
Peter ManuCristina-Mihaela LăcătuşuLiliana M. RogozeaSimona Cernea. (2022) Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine. American Journal of Therapeutics 29:4, pages e410-e424.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.